7 October
2024
Assura plc
Scrip Dividend
Declaration
Assura plc ("Assura" or "the
Company"), the diversified healthcare REIT, today announces that,
pursuant to its Scrip Dividend Scheme and in response to the scrip
dividend alternative for the quarterly interim dividend payable on
9 October 2024 (the "Scrip Dividend Alternative"), elections were
received in respect of 22.1 per cent. of the Company's ordinary
shares in issue as at the record date of 6 September
2024.
Electing shareholders will receive
ordinary shares in the Company ("Shares") in lieu of cash in
respect of this dividend and, accordingly 13,657,643 Shares (the
"New Shares") will be issued by the Company to such
shareholders.
Application has therefore been made
for the admission of the New Shares to the Official List of the
Financial Conduct Authority and to trading on the London Stock
Exchange's market for listed securities ("Admission"). The New
Shares will rank pari passu with the Company's existing ordinary
shares and Admission is expected to occur at 8.00am on 9 October
2024.
Following the allotment of the New
Shares, it is expected that the total number of shares in issue
will be 3,250,608,887 (none of which will be held in treasury) and
that, accordingly, the total number of voting rights of the Company
will be 3,250,608,887.
Copies of
the documents relating to the Scrip Dividend Alternative are
available for inspection through the National Storage Mechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism).
This interim dividend is 100%
Property Income Distribution ("PID"). Forms
to register for gross PIDs (on future interim dividends) are
available on the Company's website. Please click here for
PID Forms.
- ENDS
-
For more information, please
contact:
|
Assura plc
David Purcell, Investor Relations
Director
|
Tel: 0161 515 2043
Email: Investor@assura.co.uk
|
|
FGS
Global
Gordon Simpson
|
Tel: 0207 251 3801
Email: Assura@fgsglobal.com
|
Notes to Editors
Assura plc is the UK's leading
diversified healthcare REIT. Assura enables better health outcomes
through its portfolio of more than 600 healthcare buildings, from
which over six million patients are served.
A UK REIT based in Altrincham,
Assura is a constituent of the FTSE 250 and the EPRA* indices. As
at 31 March 2024, Assura's portfolio was valued at £2.7 billion and
has a strong track record of growing financial returns and
dividends for shareholders.
At Assura, we BUILD for health,
having developed over 100 new healthcare buildings in our history,
and at the heart of our strategy sits The Bigger Picture; Healthy
Environment (E), Healthy Communities (S), Healthy Business
(G).
Further information is available
at www.assuraplc.com
Assura plc LEI
code: 21380026T19N2Y52XF72
*EPRA is a registered trademark of
the European Public Real Estate Association.